Hattori Hiroaki, Hirayama Tsunenori, Nobe Yukiko, Nagano Makoto, Kujiraoka Takeshi, Egashira Tohru, Ishii Jun, Tsuji Masahiro, Emi Mitsuru
Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, Kawasaki, Japan.
J Hum Genet. 2002;47(2):80-7. doi: 10.1007/s100380200005.
In the course of investigations of familial coronary artery disease in Hokkaido, the northland of Japan, we identified 13 families affected by familial hypercholesterolemia. Among them, we identified eight novel mutations of the low-density lipoprotein (LDL) receptor gene, four of which caused frameshifts: (1) a 7-bp deletion at nucleotide (nt) 578-584 (codon 172-174, exon 4); (2) a 14-bp insertion at 682nt (codon 207-208, exon 4); (3) a 49-bp deletion at nt 943-991 (codon 294-310, exon 7); and (4) a one-base insertion of C to a stretch of C3 at nucleotides 1687-1689 or codon 542. The others included (5) a T-to-C transition at nt 1072 causing substitution of Cys for Arg at codon 337 (C337R, exon 8); (6) a splice-site G-to-T substitution in intron 11; (7) a splice-site G-to-C substitution in intron 11; and (8) a G-to-T transition at nt 1731 causing substitution of Trp for Cys at codon 556 (W556C, exon 12). To disclose the functional consequences of novel mutations, we characterized each of these mutations by two assays in peripheral lymphocytes, i.e., uptake of fluorescently labeled LDL by LDL receptors, and measurement of cell surface-bound LDL receptor protein using specific monoclonal antibody against LDL receptor.
在对日本北部北海道地区的家族性冠状动脉疾病进行调查的过程中,我们鉴定出了13个受家族性高胆固醇血症影响的家族。其中,我们发现了低密度脂蛋白(LDL)受体基因的8种新突变,其中4种导致移码突变:(1)核苷酸(nt)578 - 584(密码子172 - 174,外显子4)处7个碱基对的缺失;(2)682nt(密码子207 - 208,外显子4)处14个碱基对的插入;(3)nt 943 - 991(密码子294 - 310,外显子7)处49个碱基对的缺失;以及(4)在核苷酸1687 - 1689或密码子542处的一段C3中插入一个碱基C。其他突变包括:(5)nt 1072处的T到C转换,导致密码子337处的精氨酸被半胱氨酸取代(C337R,外显子8);(6)内含子11中剪接位点G到T的替换;(7)内含子11中剪接位点G到C的替换;以及(8)nt 1731处的G到T转换,导致密码子556处的半胱氨酸被色氨酸取代(W556C,外显子12)。为了揭示新突变的功能后果,我们通过在外周血淋巴细胞中的两种检测方法对每个突变进行了表征,即通过LDL受体摄取荧光标记的LDL,以及使用针对LDL受体的特异性单克隆抗体测量细胞表面结合的LDL受体蛋白。